Skip to main content
Erschienen in: Journal of Nuclear Cardiology 3/2017

01.06.2017 | Original Article

Evaluation of attenuation correction in cardiac PET using PET/MR

verfasst von: Jeffrey M. C. Lau, MD, PhD, R. Laforest, H. Sotoudeh, X. Nie, S. Sharma, J. McConathy, E. Novak, A. Priatna, R. J. Gropler, P. K. Woodard

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Simultaneous acquisition Positron emission tomography/magnetic resonance (PET/MR) is a new technology that has potential as a tool both in research and clinical diagnosis. However, cardiac PET acquisition has not yet been validated using MR imaging for attenuation correction (AC). The goal of this study is to evaluate the feasibility of PET imaging using a standard 2-point Dixon volume interpolated breathhold examination (VIBE) MR sequence for AC.

Methods and Results

Evaluation was performed in both phantom and patient data. A chest phantom containing heart, lungs, and a lesion insert was scanned by both PET/MR and PET/CT. In addition, 30 patients underwent whole-body 18F-fluorodeoxyglucose PET/CT followed by simultaneous cardiac PET/MR. Phantom study showed 3% reduction of activity values in the myocardium due to the non-inclusion of the phased array coil in the AC. In patient scans, average standardized uptake values (SUVs) obtained by PET/CT and PET/MR showed no significant difference (n = 30, 4.6 ± 3.5 vs 4.7 ± 2.8, P = 0.47). There was excellent per patient correlation between the values acquired by PET/CT and PET/MR (R 2 = 0.97).

Conclusions

Myocardial SUVs PET imaging using MR for AC shows excellent correlation with myocardial SUVs obtained by standard PET/CT imaging. The 2-point Dixon VIBE MR technique can be used for AC in simultaneous PET/MR data acquisition.
Literatur
2.
Zurück zum Zitat Torigian DA, Zaidi H, Kwee TC, Saboury B, Udupa JK, Cho ZH, et al. PET/MR imaging: Technical aspects and potential clinical applications. Radiology 2013;267:26-44.CrossRefPubMed Torigian DA, Zaidi H, Kwee TC, Saboury B, Udupa JK, Cho ZH, et al. PET/MR imaging: Technical aspects and potential clinical applications. Radiology 2013;267:26-44.CrossRefPubMed
4.
5.
Zurück zum Zitat Souvatzoglou M, Eiber M, Takei T, Fürst S, Maurer T, Gaertner F, et al. Comparison of integrated whole-body 11C-choline PET/MR with PET/CT in patients with prostate cancer. Eur J Nucl Med Mol Imaging 2013;40:1486-99.CrossRefPubMed Souvatzoglou M, Eiber M, Takei T, Fürst S, Maurer T, Gaertner F, et al. Comparison of integrated whole-body 11C-choline PET/MR with PET/CT in patients with prostate cancer. Eur J Nucl Med Mol Imaging 2013;40:1486-99.CrossRefPubMed
6.
Zurück zum Zitat Wiesmüller M, Quick HH, Navalpakkam B, Lell MM, Uder M, Ritt P, et al. Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT. Eur J Nucl Med Mol Imaging 2013;40:12-21.CrossRefPubMed Wiesmüller M, Quick HH, Navalpakkam B, Lell MM, Uder M, Ritt P, et al. Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT. Eur J Nucl Med Mol Imaging 2013;40:12-21.CrossRefPubMed
7.
Zurück zum Zitat Drzezga A, Souvatzoglou M, Eiber M, Beer AJ, Fürst S, Martinez-Möller A, et al. First clinical experience with integrated whole-body PET/MR: Comparison to PET/CT in patients with oncologic diagnoses. J Nucl Med 2012;53:845-55.CrossRefPubMed Drzezga A, Souvatzoglou M, Eiber M, Beer AJ, Fürst S, Martinez-Möller A, et al. First clinical experience with integrated whole-body PET/MR: Comparison to PET/CT in patients with oncologic diagnoses. J Nucl Med 2012;53:845-55.CrossRefPubMed
8.
Zurück zum Zitat Kim JH, Lee JS, Song IC, Lee DS. Comparison of segmentation-based attenuation correction methods for PET/MRI: Evaluation of bone and liver standardized uptake value with oncologic PET/CT data. J Nucl Med 2012;53:1878-82.CrossRefPubMed Kim JH, Lee JS, Song IC, Lee DS. Comparison of segmentation-based attenuation correction methods for PET/MRI: Evaluation of bone and liver standardized uptake value with oncologic PET/CT data. J Nucl Med 2012;53:1878-82.CrossRefPubMed
9.
Zurück zum Zitat Rischpler C, Nekolla SG, Dregely I, Schwaiger M. Hybrid PET/MR imaging of the heart: potential, initial experiences, and future prospects. J Nucl Med 2013;54:402-15.CrossRefPubMed Rischpler C, Nekolla SG, Dregely I, Schwaiger M. Hybrid PET/MR imaging of the heart: potential, initial experiences, and future prospects. J Nucl Med 2013;54:402-15.CrossRefPubMed
10.
Zurück zum Zitat Nensa F, Poeppel TD, Beiderwellen K, Schelhorn J, Mahabadi AA, Erbel R, et al. Hybrid PET/MR imaging of the heart: Feasibility and initial results. Radiology 2013;268:366-73.CrossRefPubMed Nensa F, Poeppel TD, Beiderwellen K, Schelhorn J, Mahabadi AA, Erbel R, et al. Hybrid PET/MR imaging of the heart: Feasibility and initial results. Radiology 2013;268:366-73.CrossRefPubMed
11.
Zurück zum Zitat Lau J, Laforest R, Zheng J, Lesniak D, Priatna A, Gropler R, et al. 13N-Ammonia PET/MR myocardial stress perfusion imaging early experience. J Nucl Med 2014;55:242.CrossRef Lau J, Laforest R, Zheng J, Lesniak D, Priatna A, Gropler R, et al. 13N-Ammonia PET/MR myocardial stress perfusion imaging early experience. J Nucl Med 2014;55:242.CrossRef
12.
Zurück zum Zitat Schlosser T, Nensa F, Mahabadi AA, Poeppel TD. Hybrid MRI/PET of the heart: A new complementary imaging technique for simultaneous acquisition of MRI and PET data. Heart 2013;99:351-2.CrossRefPubMed Schlosser T, Nensa F, Mahabadi AA, Poeppel TD. Hybrid MRI/PET of the heart: A new complementary imaging technique for simultaneous acquisition of MRI and PET data. Heart 2013;99:351-2.CrossRefPubMed
13.
Zurück zum Zitat Martinez-Möller A, Souvatzoglou M, Delso G, Bundschuh RA, Chefd’hotel C, Ziegler SI, et al. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: Evaluation with PET/CT data. J Nucl Med 2009;50:520-6.CrossRefPubMed Martinez-Möller A, Souvatzoglou M, Delso G, Bundschuh RA, Chefd’hotel C, Ziegler SI, et al. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: Evaluation with PET/CT data. J Nucl Med 2009;50:520-6.CrossRefPubMed
14.
Zurück zum Zitat Schulz V, Torres-Espallardo I, Renisch S, Hu Z, Ojha N, Börnert P, et al. Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data. Eur J Nucl Med Mol Imaging 2011;38:138-52.CrossRefPubMed Schulz V, Torres-Espallardo I, Renisch S, Hu Z, Ojha N, Börnert P, et al. Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data. Eur J Nucl Med Mol Imaging 2011;38:138-52.CrossRefPubMed
15.
Zurück zum Zitat Eiber M, Martinez-Möller A, Souvatzoglou M, Holzapfel K, Pickhard A, Löffelbein D, et al. Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions. Eur J Nucl Med Mol Imaging 2011;38:1691-701.CrossRefPubMed Eiber M, Martinez-Möller A, Souvatzoglou M, Holzapfel K, Pickhard A, Löffelbein D, et al. Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions. Eur J Nucl Med Mol Imaging 2011;38:1691-701.CrossRefPubMed
16.
Zurück zum Zitat Wagenknecht G, Kaiser HJ, Mottaghy FM, Herzog H. MRI for attenuation correction in PET: Methods and challenges. MAGMA 2013;26:99-113.CrossRefPubMed Wagenknecht G, Kaiser HJ, Mottaghy FM, Herzog H. MRI for attenuation correction in PET: Methods and challenges. MAGMA 2013;26:99-113.CrossRefPubMed
17.
Zurück zum Zitat Bezrukov I, Mantlik F, Schmidt H, Schölkopf B, Pichler BJ. MR-based PET attenuation correction for PET/MR imaging. Semin Nucl Med 2013;43:45-59.CrossRefPubMed Bezrukov I, Mantlik F, Schmidt H, Schölkopf B, Pichler BJ. MR-based PET attenuation correction for PET/MR imaging. Semin Nucl Med 2013;43:45-59.CrossRefPubMed
18.
Zurück zum Zitat Keereman V, Mollet P, Berker Y, Schulz V, Vandenberghe S. Challenges and current methods for attenuation correction in PET/MR. MAGMA 2013;26:81-98.CrossRefPubMed Keereman V, Mollet P, Berker Y, Schulz V, Vandenberghe S. Challenges and current methods for attenuation correction in PET/MR. MAGMA 2013;26:81-98.CrossRefPubMed
19.
Zurück zum Zitat Keller SH, Holm S, Hansen AE, Sattler B, Andersen F, Klausen TL, et al. Image artifacts from MR-based attenuation correction in clinical, whole-body PET/MRI. MAGMA 2013;26:173-81.CrossRefPubMed Keller SH, Holm S, Hansen AE, Sattler B, Andersen F, Klausen TL, et al. Image artifacts from MR-based attenuation correction in clinical, whole-body PET/MRI. MAGMA 2013;26:173-81.CrossRefPubMed
20.
Zurück zum Zitat Berker Y, Franke J, Salomon A, Palmowski M, Donker HC, Temur Y, et al. MRI-based attenuation correction for hybrid PET/MRI systems: A 4-class tissue segmentation technique using a combined ultrashort-echo-time/Dixon MRI sequence. J Nucl Med 2012;53:796-804.CrossRefPubMed Berker Y, Franke J, Salomon A, Palmowski M, Donker HC, Temur Y, et al. MRI-based attenuation correction for hybrid PET/MRI systems: A 4-class tissue segmentation technique using a combined ultrashort-echo-time/Dixon MRI sequence. J Nucl Med 2012;53:796-804.CrossRefPubMed
21.
Zurück zum Zitat Martinez-Möller A, Nekolla SG. Attenuation correction for PET/MR: problems, novel approaches and practical solutions. Z Med Phys 2012;22:299-310.CrossRefPubMed Martinez-Möller A, Nekolla SG. Attenuation correction for PET/MR: problems, novel approaches and practical solutions. Z Med Phys 2012;22:299-310.CrossRefPubMed
23.
Zurück zum Zitat Burger C, Goerres G, Schoenes S, Buck A, Lonn AH, Von Schulthess GK. PET attenuation coefficients from CT images: Experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients. Eur J Nucl Med Mol Imaging 2002;29:922-7.CrossRefPubMed Burger C, Goerres G, Schoenes S, Buck A, Lonn AH, Von Schulthess GK. PET attenuation coefficients from CT images: Experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients. Eur J Nucl Med Mol Imaging 2002;29:922-7.CrossRefPubMed
24.
Zurück zum Zitat Lau J, Laforest R, Sharma S, Priatna A, McConathy J, Amado L, et al. Feasibility of MRI attenuation correction in cardiac-gated FDG-PET. J Nucl Med 2014;54:27. Lau J, Laforest R, Sharma S, Priatna A, McConathy J, Amado L, et al. Feasibility of MRI attenuation correction in cardiac-gated FDG-PET. J Nucl Med 2014;54:27.
25.
Zurück zum Zitat Kartmann R, Paulus DH, Braun H, Aklan B, Ziegler S, Navalpakkam BK, et al. Integrated PET/MR imaging: Automatic attenuation correction of flexible RF coils. Med Phys 2013;40:082301.CrossRefPubMed Kartmann R, Paulus DH, Braun H, Aklan B, Ziegler S, Navalpakkam BK, et al. Integrated PET/MR imaging: Automatic attenuation correction of flexible RF coils. Med Phys 2013;40:082301.CrossRefPubMed
26.
Zurück zum Zitat Gambhir SS, Schwaiger M, Huang SC, Krivokapich J, Schelbert HR, Nienaber CA, et al. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med 1989;30:359-66.PubMed Gambhir SS, Schwaiger M, Huang SC, Krivokapich J, Schelbert HR, Nienaber CA, et al. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med 1989;30:359-66.PubMed
Metadaten
Titel
Evaluation of attenuation correction in cardiac PET using PET/MR
verfasst von
Jeffrey M. C. Lau, MD, PhD
R. Laforest
H. Sotoudeh
X. Nie
S. Sharma
J. McConathy
E. Novak
A. Priatna
R. J. Gropler
P. K. Woodard
Publikationsdatum
01.06.2017
Verlag
Springer US
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 3/2017
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-015-0197-1

Weitere Artikel der Ausgabe 3/2017

Journal of Nuclear Cardiology 3/2017 Zur Ausgabe

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.